B2B
ReGEN Biomedical
Maastricht, Netherlandswww.regenbiomedical.com/
ReGEN Biomedical develops automated platforms to produce robust, reproducible human micro-tissues for use in drug screening, toxicity testing, and ex vivo disease models, and works on assembling these
aliveunknown
unknown
Stage
About
ReGEN Biomedical develops automated platforms to produce robust, reproducible human micro-tissues for use in drug screening, toxicity testing, and ex vivo disease models, and works on assembling these micro-tissues into larger macro-tissues for regenerative medicine applications.
Explore ReGEN Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.